PROVECTUS PHARMACEUTICALS INC 4/A
4/A · PROVECTUS PHARMACEUTICALS INC · Filed Sep 24, 2007
Insider Transaction Report
Form 4/AAmended
ADAMS DONALD E
10% Owner
Transactions
- Sale
Common stock
2007-01-24$1.20/sh−1,500$1,800→ 5,004,477 total - Sale
Common stock
2007-02-23$1.14/sh−2,000$2,280→ 5,660,753 total - Conversion
Common stock
2006-06-08$0.74/sh+518,657$382,250→ 5,006,250 total - Sale
Common stock
2007-01-16$1.22/sh−6,000$7,320→ 5,013,977 total - Sale
Common stock
2007-02-20$1.13/sh−2,000$2,260→ 5,662,753 total - Sale
Common stock
2007-01-17$1.23/sh−2,000$2,460→ 5,011,977 total - Purchase
Common stock
2007-01-27$1.05/sh+679,048$713,000→ 5,683,525 total - Conversion
Common stock
2006-06-08+28,727→ 5,034,977 total - Sale
Common stock
2007-03-07$1.15/sh−4,000$4,600→ 5,654,753 total - Sale
Common stock
2006-08-11$1.13/sh−15,000$16,950→ 5,019,977 total - Sale
Common stock
2007-03-19$1.24/sh−2,000$2,480→ 5,652,753 total - Sale
Common stock
2007-04-11$1.45/sh−630$914→ 5,646,123 total - Sale
Common stock
2007-02-06$1.13/sh−4,000$4,520→ 5,677,525 total - Sale
Common stock
2007-09-04$2.08/sh−20,000$41,500→ 5,626,123 total - Sale
Common stock
2007-01-31$1.17/sh−2,000$2,340→ 5,681,525 total - Sale
Common stock
2007-09-06$2.80/sh−50,000$140,000→ 5,551,123 total - Sale
Common stock
2007-01-22$1.20/sh−6,000$7,200→ 5,005,977 total - Sale
Common stock
2007-02-13$1.12/sh−8,000$8,960→ 5,664,753 total - Sale
Common stock
2007-09-05$2.40/sh−25,000$60,000→ 5,601,123 total - Sale
Common stock
2007-03-21$1.29/sh−2,000$2,580→ 5,650,753 total - Sale
Common stock
2007-09-06$2.86/sh−5,000$14,300→ 5,546,123 total - Sale
Common stock
2007-02-07$1.15/sh−4,772$5,488→ 5,672,753 total - Conversion
$382,250 8% Convertible Note
2006-06-08$0.74/sh+547,384$403,422→ 0 totalExercise: $0.74From: 2005-11-26Exp: 2006-11-26→ Common Stock (547,384 underlying) - Sale
Common stock
2007-03-02$1.14/sh−2,000$2,280→ 5,658,753 total - Sale
Common stock
2007-04-03$1.47/sh−4,000$5,880→ 5,646,753 total
Footnotes (6)
- [F1]Issued upon the conversion of an 8% Convertible Note in the principal amount of $382,250 reported on Form 3, dated March 29, 2006, at a conversion price of $0.737 per share.
- [F2]Shares received in satisfaction of accrued and unpaid interest of Convertible Note described above.
- [F3]Shares purchased in a Private Placement under Regulation D of the Securities Act of 1933, as amended.
- [F4]Convertible Note was convertible into shares of Common Stock at any time at the sole discretion of the Reporting Person.
- [F5]Does not include (i) 1,116,667 shares of Common Stock issuable upon the exercise of a warrant at a purchase price of $0.935 per share and expiring on December 31, 2010 and (ii) 533,333 shares of Common Stock issuable upon the exercise of a warrant at a purchase price of $0.99per share and expiring on March 30, 2010.
- [F6]Consists of (i) 518,657 shares of Common Stock issued upon the conversion of the principal amount of the Convertible Note and (ii) 28,727 shares of Common Stock issued in satisfaction of accrued and unpaid interest on the Convertible Note.